A CASE OF MONOCLONAL ANTIBODY (RITUXIMAB) INDUCED POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS. RJDNMD 2024, 31 (1), 698-704.